POLAR: Psychosocial effects of corona measures in people with Alzheimer's
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202023Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr WM. prof van der FlierResearch Location
N/ALead Research Institution
Amsterdam UMC Locatie VUmcResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
POLAR aims to make people with Alzheimer's more resilient to the consequences of the corona measures. They are having a hard time during corona. Not only are patients extra susceptible to the virus, informal caregivers are also hit hard by the measures. Most people with Alzheimer's live at home and use (in)formal care and support networks. Formal care concerns, for example, case management and daytime activities and these have often stopped due to the measures. This has increased the pressure on informal caregivers considerably. POLAR maps the effects of corona on the patient's behavior, mood and functioning, burden on loved ones and care use. In addition, online information tools are being developed about dealing with the consequences of the corona measures. This contributes to positively influencing the support system around people with Alzheimer's during and after COVID-19. POLAR is a collaboration between the Amsterdam Alzheimer Center, Amsterdam UMC, Alzheimer Netherlands and Pharos. First results During the second lockdown, patients and healthcare providers adapted better to the challenges of the lockdown. The psychosocial and behavioral effects decreased and patients experienced more social support compared to the first lockdown. Support from family and friends appears to be an important protective factor for negative outcomes in patients and caregivers. The first results were published in January 2022 published in the Journal of Alzheimer's Disease.